Global investment firm The Carlyle announced it has reached an agreement to acquire the entire shareholding in Forgital, a manufacturing company producing large forged and machined components for use in the aerospace and industrial industries, controlled by members of founding Spezzapria family and, with a minority stake, by Fondo Italiano d’Investimento, managed by Neuberger Berman.
The transaction, which values Forgital at approximately 1 billion Euros, is expected to be completed in the second half of 2019, subject to customary closing requirements and regulatory approvals. Funds for the investment will come from Carlyle Europe Partners V (CEP V), a European-focused upper-mid market buyout fund and from Carlyle Partners VII (CP VII), a US-focused buyout fund.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan